Year: 2019

Bayer shares rose as much as 3.5% on Monday, reaching their highest level in 14 months, after the United States government said that a $25 million glyphosate decision against the company should be reversed. The U.S. Environmental Protection Agency and the Justice Department on Friday said in a friend of the court brief a federal appeals court should reverse a lower court verdict finding the company liable in the case of a man who blamed the weed killer by Bayer’s U.S. unit Monsanto for his cancer. Bayer denies its Roundup weed killer causes cancer. …read more […]

Dec.23 — Gareth McCartney, head of EMEA equity capital markets at UBS, discusses the current state of markets and where he sees them heading in 2020. He speaks on “Bloomberg Markets: European Open.” …read more […]

The logistics unit of Chinese e-commerce company JD.com Inc has held early discussions with banks about a potential overseas IPO that could raise $8 billion to $10 billion, two people with direct knowledge of the matter told Reuters. JD Logistics is targeting a valuation of at least $30 billion, according to the people, who declined to be named as the information is confidential. The unit is expected to select banks for the initial public offering (IPO) in the second quarter of next year and will use the funds for warehouse expansion and potential acquisition purposes, one person …read more […]

Credit Suisse on Monday cleared CEO Tidjane Thiam and other top executives from knowledge of a second spying incident, saying former Chief Operating Officer Pierre-Olivier Bouee had the Swiss bank’s then-head of human resources followed in February and covered it up. Switzerland’s second-biggest bank confirmed it was behind the second internal spying scandal to surface this year after a newspaper report last week detailed former HR head Peter Goerke’s tailing. The matter comes as an embarrassment to Credit Suisse after an earlier probe into spying on wealth management executive Iqbal Khan depicted the incident as a one-off. …read more […]

Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying… …read more […]

The Bank of Italy “positively” fulfilled its supervision duties and is ready to account for its actions on failing lender Banca Popolare di Bari, Governor Ignazio Visco told Corriere della Sera daily in an interview published on Monday. Prosecutors in the southern Italian town of Bari are investigating the former chairman of Popolare di Bari for alleged corruption in relation to the central bank’s supervisory activity over the failing local lender, a judicial source said on Sunday. “Banking supervision has accomplished its duties with the highest effort and, in my opinion, positively,” Visco told Il Corriere, adding that …read more […]

Roche entered into a $1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD) outside the United States. Roche will make an upfront payment of $750 million in cash and $400 million worth in equity at closing for Sarepta’s investigational micro-dystrophin gene therapy SRP-9001 that is currently in clinical development, the Swiss drugmaker said in a statement on Monday. …read more […]